Bariatric surgery for type 2 diabetes

@article{Dixon2012BariatricSF,
  title={Bariatric surgery for type 2 diabetes},
  author={John B. Dixon and Carel W. le Roux and Francesco Rubino and Paul Z. Zimmet},
  journal={The Lancet},
  year={2012},
  volume={379},
  pages={2300-2311}
}
Bariatric surgery provides substantial, sustained weight loss and major improvements in glycaemic control in severely obese individuals with type 2 diabetes. However, uptake of surgery in eligible patients is poor, and the barriers are difficult to surmount. We examine the indications for and efficacy and safety of conventional bariatric surgical procedures and their effect on glycaemic control in type 2 diabetes. How surgical gastrointestinal interventions achieve these changes is of great… Expand
Gastrointestinal weight loss surgery for the management of type 2 diabetes: A view from Greece
TLDR
Evidence is provided that surgical procedures bypassing parts of the small intestine improve glucose homeostasis through mechanisms beyond reduced food intake and body weight, which should facilitate the design of novel anti-diabetic gastrointestinal manipulations, devices and pharmacotherapeutics for obese and non-obese diabetic patients. Expand
Bariatric surgery or medicine for type 2 diabetes?
TLDR
Larger studies are needed to determine whether one of these procedures is better, or if they are all similarly effective, and this should be weighed against the risk of the operations. Expand
Metabolic surgery for type 2 diabetes: efficacy and risks
TLDR
Understanding the efficacy and physiologic effects of bariatric surgery on metabolism will help guide patient management in the context of a growing epidemic of obesity and T2DM, and may also enable us to develop less invasive but equally effective therapeutic strategies for weight loss and metabolic control. Expand
Glycaemic Control and Reduction of Cardiovascular Risk Following Bariatric Surgery
TLDR
This chapter will outline the differential effects of each of the current most common bariatric procedures on CV risk factors. Expand
Assessing the obese diabetic patient for bariatric surgery: which candidate do I choose?
TLDR
At present, Roux-en-Y gastric bypass seems the surgical procedure of choice because it has fewer risks than biliopancreatic diversion, and it is associated with higher weight loss and metabolic improvements compared with adjustable gastric banding. Expand
Gastrointestinal Surgery: Cardiovascular Risk Reduction and Improved Long-Term Survival in Patients with Obesity and Diabetes
TLDR
The opportunity for bariatric (and/or metabolic) surgery to provide a preventive strategy for cardiovascular disease and diabetes as well as treatment therapy is presented for clinical consideration. Expand
Surgery for Severe Obesity
TLDR
This state-of-the-art review focuses on the research and resultant recommendations regarding lifestyle management for patients who have undergone bariatric surgery. Expand
Bariatric surgery as a treatment option in patients with type 2 diabetes mellitus.
TLDR
The elucidation of the mechanisms underpinning the resolution of T2DM following bariatric surgery might result in the development of novel, more effective pharmacotherapies for this common disease. Expand
Bariatric surgery: traversing the CROSSROADS into mainstream diabetes care
TLDR
The CROSSROADS study was very successful in achieving weight loss and reducing markers of metabolic dysfunction, including HbA1c and fasting insulin concentrations in both arms, however, in keeping with previous studies on the effect of intensive lifestyle interventions on metabolic control in diabetes, and on weight loss, the initial improvements were not sustainable without the addition of surgery. Expand
Gastric Bypass for Type 2 Diabetes Mellitus on BMI < 35
TLDR
Bariatric surgery can cause resolution of the clinical manifestations of type 2 diabetes, as well as improvement, and metabolic surgery is the only diabetes treatment proven to result in long-term remission in 23–60% of patients depending upon preoperative duration of diabetes and disease severity. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 144 REFERENCES
IDF's view of bariatric surgery in type 2 diabetes
TLDR
The IDF statement recognises that bariatric surgery is an appropriate treatment for obese people with type 2 diabetes who do not achieve recommended targets with available therapies, especially in cases with other major comorbidities (eg, hypertension and dyslipidaemia). Expand
Bariatric Surgery on Type 2 Diabetes Mellitus Patients in Japan
TLDR
Promoting weight loss without rebound is a major issue in treatment, especially in severely obese patients, and there has been an increase in patients with a BMI>35 undergoing bariatric surgery. Expand
Bariatric surgery: an IDF statement for obese Type 2 diabetes.
The International Diabetes Federation Taskforce on Epidemiology and Prevention of Diabetes convened a consensus working group of diabetologists, endocrinologists, surgeons and public health expertsExpand
Bariatric surgery: unstressing or boosting the β‐cell?
TLDR
Interestingly, a net improvement up to resolution of type 2 diabetes has been consistently reported few days after RYGB and BPD, and the mechanism allowing diabetes resolution after surgical intestinal manipulation is extremely interesting but only partially understood. Expand
Narrative Review: Effect of Bariatric Surgery on Type 2 Diabetes Mellitus
TLDR
Glycemic control in diabetic patients improves markedly within days of bariatric surgery, which suggests that the procedures alter the hormones that control insulin secretion, including ghrelin and peptide YY (PYY). Expand
Endocrine mechanisms mediating remission of diabetes after gastric bypass surgery
  • D. Cummings
  • Medicine
  • International Journal of Obesity
  • 2009
TLDR
Weight-independent antidiabetic actions of RYGB are apparent because of the very rapid resolution of T2DM, the greater improvement of glucose homeostasis after RY GB than after an equivalent weight loss from other means, and the occasional development of very late-onset, pancreatic β-cell hyperfunction. Expand
Clinical Improvement After Duodenojejunal Bypass for Nonobese Type 2 Diabetes Despite Minimal Improvement in Glycemic Homeostasis
TLDR
Clinical improvement was obvious in all of the seven patients undergoing laparoscopic duodenojejunal bypass, but LDJB may not be effective at inducing remission of T2DM and the MS in certain patients undergoing this operation. Expand
Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis.
TLDR
The clinical and laboratory manifestations of type 2 diabetes are resolved or improved in the greater majority of patients after bariatric surgery; these responses are more pronounced in procedures associated with a greater percentage of excess body weight loss and is maintained for 2 years or more. Expand
Effects of bariatric surgery on mortality in Swedish obese subjects.
TLDR
Bariatric surgery for severe obesity is associated with long-term weight loss and decreased overall mortality. Expand
Comparative effectiveness of bariatric surgery and nonsurgical therapy in adults with type 2 diabetes mellitus and body mass index <35 kg/m2.
TLDR
RYGB can be performed in patients with both a BMI <35 kg/m(2) and T2DM with better weight loss, glycemic control, and fewer antihyperglycemic medications than NSC, and may partially explain the persistent increase in both SBP and LDL after RYGB. Expand
...
1
2
3
4
5
...